Scope of the Report: This report focuses on the Rosuvastatin in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers AstraZeneca Teva Pharmaceutical Industries MSN Laboratories Cadila Pharmaceuticals LGM Pharma Bal Pharma Changzhou Pharmaceutical Factory Jingxin Pharm Zhejiang Hisun Pharmaceutical HEC Pharm Lunan Pharmaceutical Nanjing Frochem Tech Lianyungang Runzhong Pharmaceutical Shandong Bechem Chemicals CTX Life Sciences. Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Purity 98.0% Purity 99.0% Market Segment by Applications, can be divided into Tablet Capsule There are 17 Chapters to deeply display the Europe Rosuvastatin market. Chapter 1, to describe Rosuvastatin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Rosuvastatin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Rosuvastatin, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Rosuvastatin market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Rosuvastatin sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Rosuvastatin Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Rosuvastatin Introduction 1.2 Market Analysis by Type 1.2.1 Purity 98.0% 1.2.2 Purity 99.0% 1.3 Market Analysis by Applications 1.3.1 Tablet 1.3.2 Capsule 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (2012-2022) 1.4.2 France Status and Prospect (2012-2022)
